Publications by authors named "Simon Risanger"
Rapid diagnostic testing for COVID-19 is key to guiding social distancing orders and containing emerging disease clusters by contact tracing and isolation. However, communities throughout the US do not yet have adequate access to tests. Pharmacies are already engaged in testing, but there is capacity to greatly increase coverage.
View Article and Find Full Text PDFWidespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative evidence that even a subset of USPS facilities could provide broad access, particularly in remote and at-risk communities with limited access to health care.
View Article and Find Full Text PDFArticle Synopsis
- - Rapid diagnostic testing for COVID-19 is crucial for effective social distancing and managing disease spread, but many US communities still lack adequate testing access.
- - Research shows that if COVID-19 testing were available at all US pharmacies, about 94% of the population would be willing to travel for it, but different regions have varying needs for testing locations.
- - Using a facility location optimization model, it’s found that strategically selecting pharmacies for testing can greatly increase access, potentially reaching 29 million more people compared to just choosing based on population density.